Method and Pesticidal Mixtures for Controlling Pentatomidae Pests

Abstract

The invention relates to a method for controlling pests from the family of Pentatonidae, comprising the step of contacting the pests, their food supply, habitat or breeding grounds with a pesticidal mixture comprising as active compound I at least one component of the ginkgo tree I, selected from the group consisting of bilobalide, ginkgolide A, ginkgolide B, ginkgolide C, ginkgolide J and ginkgolide M, and at least one pesticidally active compound II and/or at least one fungicidally active compound III, as defined in the description, in a synergistically effective amount.

The invention further relates to certain of these mixtures.

Claims

1-22. (canceled)

23. A method for controlling pests from the family of Pentatonidae, comprising the step of contacting the pests, their food supply, habitat or breeding grounds with a pesticidal mixture comprising as active compounds 1) at least one compound I, which is a component of the ginkgo tree selected from the group consisting of bilobalide, ginkgolide A, ginkgolide B, ginkgolide C, ginkgolide J and ginkgolide M, and at least one pesticidally active compound II selected from groups M and/or L consisting of II-M.1 Acetylcholine esterase inhibitors: II-M.1A carbamates: aldicarb, alanycarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb and triazamate; and II-M.1B organophosphates, for example acephate, azamethiphos, azinphos-ethyl, azinphosmethyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl O-(methoxyaminothio-phosphoryl) salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon and vamidothion; II-M.2. GABA-gated chloride channel antagonists: II-M.2A cyclodiene organochlorine compounds: endosulfan or chlordane; and II-M.2B fiproles: ethiprole, fipronil, flufiprole, pyrafluprole and pyriprole; II-M.3 Sodium channel modulators: II-M.3A pyrethroids: acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S-cylclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, heptafluthrin, imiprothrin, meperfluthrin, metofluthrin, momfluorothrin, permethrin, phenothrin, prallethrin, profluthrin, pyrethrin (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethylfluthrin, tetramethrin, tralomethrin, and transfluthrin; and II-M.3B sodium channel modulators: DDT, and methoxychlor; II-M.4 Nicotinic acetylcholine receptor agonists: II-M.4A neonicotinoids: acetamiprid, clothianidin, cycloxaprid, dinotefuran, imidacloprid, nitenpyram, thiacloprid, and thiamethoxam; II-M.4A.2 (2E-)-1-[(6-Chloropyridin-3-yl)methyl]-N′-nitro-2-pentylidenehydrazinecarboximidamide; II-M4.A.3 1-[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro-5-propoxy-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine; and II-M.4B nicotine; II-M.5 Nicotinic acetylcholine receptor allosteric activators from the class of spinosyns: spinosad, and spinetoram; II-M.6 Chloride channel activators from the class of avermectins and milbemycins: abamectin, emamectin benzoate, ivermectin, lepimectin, and milbemectin; II-M.7 Juvenile hormone mimics: II-M.7A juvenile hormone analogues: hydroprene, kinoprene, and methoprene; and II-M.7B fenoxycarb, and pyriproxyfen; II-M.8 miscellaneous non-specific inhibitors: II-M.8A alkyl halides: methyl bromide, and other alkyl halides; and II-M.8B chloropicrin, sulfuryl fluoride, borax, and tartar emetic; II-M.9 Selective homopteran feeding blockers: pymetrozine, and flonicamid; II-M.10 Mite growth inhibitors: clofentezine, hexythiazox, diflovidazin, and etoxazole; II-M.11 Microbial disruptors of insect midgut membranes: bacillus thuringiensis, bacillus sphaericus, and the insecticdal proteins they produce: bacillus thuringiensis subsp. israelensis, bacillus sphaericus, bacillus thuringiensis subsp. aizawai and bacillus thuringiensis subsp. tenebrionis, or the Bt crop proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb and Cry34/35Ab1; II-M.12 Inhibitors of mitochondrial ATP synthase: II-M.12A diafenthiuron, and organotin miticides: azocyclotin, cyhexatin, and fenbutatin oxide; and II-M.12B propargite, and tetradifon; II-M.13 Uncouplers of oxidative phosphorylation via disruption of the proton gradient: chlorfenapyr, DNOC, and sulfluramid; II-M.14 Nicotinic acetylcholine receptor channel blockers: bensultap, cartap hydrochloride, thiocyclam, and thiosultap sodium; II-M.15 Inhibitors of the chitin biosynthesis type 0: bistrifluron, chlorfluazuron, diflubenzuron, flueycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, and triflumuron; II-M.16 Inhibitors of the chitin biosynthesis type 1: buprofezin; II-M.17 Moulting disruptors: cyromazine; II-M.18 Ecdyson receptor agonists: methoxyfenozide, tebufenozide, halofenozide, fufenozide or chromafenozide; II-M.19 Octopamin receptor agonists: amitraz; II-M.20 Mitochondrial complex III electron transport inhibitors: hydramethylnon, acequinocyl, and fluacrypyrim; II-M.21 Mitochondrial complex I electron transport inhibitors: II-M.21A METI acaricides and insecticides: fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, and tolfenpyrad; and II-M.21B rotenone; II-M.22 Voltage-dependent sodium channel blockers: II-M.22A indoxacarb; II-M.22B metaflumizone; II-M.22B.1 2-[2-(4-Cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]-hydrazinecarboxamide; and II-M.22B.2 N-(3-Chloro-2-methylphenyl)-2-[(4-chlorophenyl)[4-[methyl(methylsulfonyl)amino]phenyl]methylene]-hydrazinecarboxamide; II-M.23 Inhibitors of the of acetyl CoA carboxylase of the class of tetronic and tetramic acid derivatives: spirodiclofen, spiromesifen, and spirotetramat; II-M.24 Mitochondrial complex IV electron transport inhibitors: II-M.24A phosphorous compounds: aluminium phosphide, calcium phosphide, phosphine, and zinc phosphide; and II-M.24B cyanide; II-M.25 Mitochondrial complex II electron transport inhibitors from the class of beta-ketonitrile derivatives: cyenopyrafen, and cyflumetofen; II-M.28 Ryanodine receptor-modulators from the class of diamides: flubendiamide, chlorantraniliprole (Rynaxypyr®), cyantraniliprole (Cyazypyr®), tetraniliprole; and the phthalamide compounds II-M.28.1 (R)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid; II-M.28.2 (S)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid; II-M.28.3 3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chlorpyridin-2-yl)-1H-pyrazole-5-carboxamide (proposed ISO name: cyclaniliprole); II-M.28.4 methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylate; II-M.28.5a N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; IIM.28.5b N-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; II-M.28.5c N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; II-M.28.5d N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; II-M.28.5h N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; II-M.28.5i N-[2-(5-Amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide; II-M.28.5j 3-Chloro-1-(3-chloro-2-pyridinyl)-N-[2,4-dichloro-6-[[(1-cyano-1-methylethyl)amino]carbonyl]phenyl]-1H-pyrazole-5-carboxamide; II-M.28.5k 3-Bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-1-(3,5-dichloro-2-pyridyl)-1H-pyrazole-5-carboxamide; II-M.28.5l N-[4-Chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide; and II-M.28.6: cyhalodiamide; II-M.29. insecticidal active compounds of unknown or uncertain mode of action: afidopyropen, afoxolaner, azadirachtin, amidoflumet, benzoximate, bifenazate, broflanilide, bromopropylate, chinomethionat, cryolite, dicloromezotiaz, dicofol, flufenerim, flometoquin, fluensulfone, fluhexafon, fluopyram, flupyradifurone, fluralaner, metoxadiazone, piperonyl butoxide, pyflubumide, pyridalyl, pyrifluquinazon, sulfoxaflor, tioxazafen, and triflumezopyrim; II-M.29.3: 11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one; II-M.29.4: 3-(4′-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one; II-M.29.5: 1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine, and actives on basis of bacillus firmus (Votivo, 1-1582); and II-M.29.6a (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; II-M.29.6b (E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; II-M.29.6c (E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridylidene]acetamide; II-M.29.6d (E/Z)-N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; II-M.29.6e (E/Z)-N-[1-[1-(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; II-M.29.6f (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide; II-M.29.6g (E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide; II-M.29.6h (E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; II-M.29.6i (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoro-propanamide.); II-M.29.6j N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-thioacetamide; and II-M.29.6k N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-N′-isopropyl-acetamidine; II-M.29.8: fluazaindolizine; II-M.29.9.a 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide; and II-M.29.9.b fluxametamide; II-M.29.10 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1H-pyrazole; II-M.29.11.b 3-(benzoylmethylamino)-N-[2-bromo-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]-6-(trifluoromethyl)phenyl]-2-fluoro-benzamide; II-M.29.11.c 3-(benzoylmethylamino)-2-fluoro-N-[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]-benzamide; II-M.29.11.d N-[3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; II-M.29.11.e N-[3-[[[2-bromo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]-2-fluorophenyl]-4-fluoro-N-methyl-benzamide; II-M.29.11.f 4-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; II-M.29.11.g 3-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; II-M.29.11.h 2-chloro-N-[3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-3-pyridinecarboxamide; II-M.29.11.i 4-cyano-N-[2-cyano-5-[[2,6-dibromo-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; II-M.29.11.j 4-cyano-3-[(4-cyano-2-methyl-benzoyl)amino]-N-[2,6-dichloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]-2-fluoro-benzamide; II-M.29.11.k N-[5-[[2-chloro-6-cyano-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]-phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; II-M.29.11.l N-[5-[[2-bromo-6-chloro-4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]-phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; II-M.29.11.m N-[5-[[2-bromo-6-chloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; II-M.29.11.n 4-cyano-N-[2-cyano-5-[[2,6-dichloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; II-M.29.11.o 4-cyano-N-[2-cyano-5-[[2,6-dichloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; II-M.29.11.p N-[5-[[2-bromo-6-chloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]-carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; II-M.29.12.a 2-(1,3-Dioxan-2-yl)-6-[2-(3-pyridinyl)-5-thiazolyl]-pyridine; II-M.29.12.b 2-[6-[2-(5-Fluoro-3-pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine; II-M.29.12.c 2-[6-[2-(3-Pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine; II-M.29.12.d N-Methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide; II-M.29.12.e N-Methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide; II-M.29.12.f N-Ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide; II-M.29.12.g N-Methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide; II-M.29.12.h N,2-Dimethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide; II-M.29.12.i N-Ethyl-2-methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide; II-M.29.12.j N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-2-methyl-3-methylthio-propanamide; II-M.29.12.k N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N,2-dimethyl-3-methylthio-propanamide; II-M.29.12.l N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-methyl-3-methylthio-propanamide; II-M.29.12.m N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-3-methylthio-propanamide; or the compounds II-M.29.14a 1-[(6-Chloro-3-pyridinyl)methyl]-1,2,3,5,6,7-hexahydro-5-methoxy-7-methyl-8-nitro-imidazo[1,2-a]pyridine; II-M.29.14b 1-[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridin-5-ol; II-M.29.16a 1-isopropyl-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; or II-M.29.16b 1-(1,2-dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.16c N,5-dimethyl-N-pyridazin-4-yl-1-(2,2,2-trifluoro-1-methyl-ethyl)pyrazole-4-carboxamide; II-M.29.16d 1-[1-(1-cyanocyclopropyl)ethyl]-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.16e N-ethyl-1-(2-fluoro-1-methyl-propyl)-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.16f 1-(1,2-dimethylpropyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.16g 1-[1-(1-cyanocyclopropyl)ethyl]-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.16h N-methyl-1-(2-fluoro-1-methyl-propyl]-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.16i 1-(4,4-difluorocyclohexyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; and II-M.29.16j 1-(4,4-difluorocyclohexyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.17a N-(1-methylethyl)-2-(3-pyridinyl)-2H-indazole-4-carboxamide; II-M.29.17b N-cyclopropyl-2-(3-pyridinyl)-2H-indazole-4-carboxamide; II-M.29.17c N-cyclohexyl-2-(3-pyridinyl)-2H-indazole-4-carboxamide; II-M.29.17d 2-(3-pyridinyl)-N-(2,2,2-trifluoroethyl)-2H-indazole-4-carboxamide; II-M.29.17e 2-(3-pyridinyl)-N-[(tetrahydro-2-furanyl)methyl]-2H-indazole-5-carboxamide; II-M.29.17f methyl 2-[[2-(3-pyridinyl)-2H-indazol-5-yl]carbonyl]hydrazinecarboxylate; II-M.29.17g N-[(2,2-difluorocyclopropyl)methyl]-2-(3-pyridinyl)-2H-indazole-5-carboxamide; II-M.29.17h N-(2,2-difluoropropyl)-2-(3-pyridinyl)-2H-indazole-5-carboxamide; II-M.29.17i 2-(3-pyridinyl)-N-(2-pyrimidinylmethyl)-2H-indazole-5-carboxamide; and II-M.29.17j N-[(5-methyl-2-pyrazinyl)methyl]-2-(3-pyridinyl)-2H-indazole-5-carboxamide; II-M.29.18a N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropylsulfanyl)-propanamide; II-M.29.18b N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropylsulfinyl)-propanamide; II-M.29.18c N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)-methylsulfanyl]-N-ethyl-propanamide; and II-M.29.18d N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)-methylsulfinyl]-N-ethyl-propanamide; II-M.29.19 sarolaner; II-M.29.20 lotilaner; II-L Biopesticides: II-L.1 Microbial pesticides with fungicidal, bactericidal, viricidal and/or plant defense activator activity: Ampelomyces quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus altitudinis, B. amyloliquefaciens, B. megaterium, B. mojavensis, B. mycoides, B. simplex, B. solisalsi, B. subtilis, B. subtilis var. amyloliquefaciens, Candida oleophila, C. saitoana, Clavibacter michiganensis (bacteriophages), Coniothyrium minitans, Cryphonectria parasitica, Cryptococcus albidus, Dilophosphora alopecuri, Fusarium oxysporum, Clonostachys rosea f. catenulate (also named Gliocladium catenulatum), Gliocladium roseum, Lysobacter antibioticus, L. enzymogenes, Metschnikowia fructicola, Microdochium dimerum, Microsphaeropsis ochracea, Muscodor albus, Paenibacillus polymyxa, Pantoea vagans, Penicillium bilaiae, Phlebiopsis gigantea, Pseudomonas sp., Pseudomonas chloraphis, Pseudozyma flocculosa, Pichia anomala, Pythium oligandrum, Sphaerodes mycoparasitica, Streptomyces griseoviridis, S. lydicus, S. violaceusniger, Talaromyces flavus, T. asperellum, T. atroviride, T. fertile, T. gamsii, T. harmatum, T. harzianum, T. polysporum, T. stromaticum, T. virens, T. viride, Typhula phacorrhiza, Ulocladium oudemansii, Verticillium dahlia, and zucchini yellow mosaic virus (avirulent strain); II-L.2Biochemical pesticides with fungicidal, bactericidal, viricidal and/or plant defense activator activity: harpin protein, and Reynoutria sachalinensis extract; II-L.3 Microbial pesticides with insecticidal, acaricidal, molluscidal and/or nematicidal activity: Agrobacterium radiobacter, Bacillus cereus, B. firmus, B. thuringiensis, B. thuringiensis ssp. aizawai, B. t. ssp. israelensis, B. t. ssp. galleriae, B. t. ssp. tenebrionis, Beauveria bassiana, B. brongniartii, Burkholderia spp., Chromobacterium subtsugae, Cydia pomonella granulovirus (CpGV), Cryptophlebia leucotreta granulovirus (CrleGV), Flavobacterium spp., Helicoverpa armigera nucleopolyhedrovirus (HearNPV), Helicoverpa zea nucleopolyhedrovirus (HzNPV), Helicoverpa zea single capsid nucleopolyhedrovirus (HzSNPV), Heterorhabditis bacteriophora, Isaria fumosorosea, Lecanicillium longisporum, L. muscarium, Metarhizium anisopliae, Metarhizium anisopliae var. anisopliae, M. anisopliae var. acridum, Nomuraea rileyi, Paecilomyces fumosoroseus, P. lilacinus, Paenibacillus popilliae, Pasteuria spp., P. nishizawae, P. penetrans, P. ramosa, P. thornea, P. usgae, Pseudomonas fluorescens, Spodoptera littoralis nucleopolyhedrovirus (SpliNPV), Steinernema carpocapsae, S. feltiae, S. kraussei, Streptomyces galbus, and S. microflavus; II-L.4Biochemical pesticides with insecticidal, acaricidal, molluscidal, pheromone and/or nematicidal activity: L-carvone, citral, (E,Z)-7,9-dodecadien-1-yl acetate, ethyl formate, (E,Z)-2,4-ethyl decadienoate (pear ester), (Z,Z,E)-7,11,13-hexadecatrienal, heptyl butyrate, isopropyl myristate, lavanulyl senecioate, cis-jasmone, 2-methyl 1-butanol, methyl eugenol, methyl jasmonate, (E,Z)-2,13-octadecadien-1-ol, (E,Z)-2,13-octadecadien-1-ol acetate, (E,Z)-3,13-octadecadien-1-ol, R-1-octen-3-ol, pentatermanone, (E,Z,Z)-3,8,11-tetradecatrienyl acetate, (Z,E)-9,12-tetradecadien-1-yl acetate, Z-7-tetradecen-2-one, Z-9-tetradecen-1-yl acetate, Z-11-tetradecenal, Z-11-tetradecen-1-ol, extract of Chenopodium ambrosiodes, Neem oil, and Quillay extract; II-L.5 Microbial pesticides with plant stress reducing, plant growth regulator, plant growth promoting and/or yield enhancing activity: A. lipoferum, A. irakense, A. halopraeferens, B. elkanii, B. liaoningense, B. lupini, Delftia acidovorans, Glomus intraradices, Mesorhizobium spp., Rhizobium leguminosarum bv. phaseoli, R. l. bv. trifolii, R. l. bv. viciae, R. tropici, and Sinorhizobium meliloti; and/or at least one fungicidally active compound III selected from III-F.I Respiration inhibitors III-F.I1 Inhibitors of complex III at Q.sub.o site: azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fenaminstrobin, fenoxy-strobin/flufenoxystrobin, fluoxastrobin, kresoxim-methyl, mandestrobin, meto-minostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, trifloxystrobin, 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylidene-aminooxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide, pyribencarb, triclopyricarb/chlorodincarb, famoxadone, and fenamidone, methyl-N-[2-[(1,4-dimethyl-5-phenyl-pyrazol-3-yl)oxylmethyl]phenyl]-N-methoxy-carbamate, 1-[3-chloro-2-[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one, 1-[3-bromo-2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxy-methyl]phenyl]-4-methyl-tetrazol-5-one, 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one, 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one, 1-[2-[[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one, 1-[2-[[4-(4-chlorophenyl)thiazol-2-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one, 1-[3-chloro-2-[[4-(p-tolyl)thiazol-2-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one, 1-[3-cyclopropyl-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one, 1-[3-(difluoromethoxy)-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one, 1-methyl-4-[3-methyl-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]tetrazol-5-one, 1-methyl-4-[3-methyl-2-[[1-[3-(trifluoromethyl)phenyl]-ethylideneamino]oxy-methyl]phenyl]tetrazol-5-one, (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, (Z,2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, and (Z,2E)-5-[1-(4-chloro-2-fluoro-phenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide; III-F.I2 inhibitors of complex III at Q.sub.i site: cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8-benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1, 5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1,3-benzodioxol-5-ylmethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate; (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl 2-methylpropanoate, and (3S,6S,7R,8R)-8-benzyl-3-[3-[(isobutyryloxy)methoxy]-4-methoxypicolinamido]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl isobutyrate; III-F.I3 inhibitors of complex II: benodanil, benzovindiflupyr, bixafen, boscalid, carboxin, fenfuram, fluopyram, flutolanil, fluxapyroxad, furametpyr, isofetamid, isopyrazam, mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane, tecloftalam, thifluzamide, N-(4′-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)-pyrazole-4-carboxamide, 1,3,5-trimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, N-(7-fluoro-1,1,3-trimethyl-indan-4-yl)-1,3-dimethyl-pyrazole-4-carboxamide, and N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide; III-F.I4 other respiration inhibitors: diflumetorim, (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl}-amine; nitrophenyl derivates: binapacryl, dinobuton, dinocap, fluazinam, ferimzone; organometal compounds: fentin-acetate, fentin chloride, and fentin hydroxide; ametoctradin; and silthiofam; III-F.II Sterol biosynthesis inhibitors: III-F.II1 C14 demethylase inhibitors: triazoles: azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, oxpoconazole, paclobutrazole, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, 1-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-5-thiocyanato-1H-[1,2,4]triazolo, 2-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol, 1-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-cyclopropyl-2-(1,2,4-triazol-1-yl)ethanol, 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol, 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1-(1, 2,4-triazol-1-yl)butan-2-ol, 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)-phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol, 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol, 2-[4-(4-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)pent-3-yn-2-ol; imidazoles: imazalil, pefurazoate, prochloraz, triflumizol; pyrimidines, pyridines and piperazines: fenarimol, nuarimol, pyrifenox, triforine, and [3-(4-chloro-2-fluoro-phenyl)-5-(2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol; III-F.II2 Delta14-reductase inhibitors: aldimorph, dodemorph, dodemorph-acetate, fenpropimorph, tridemorph, fenpropidin, piperalin, and spiroxamine; III-F.II3 Inhibitors of 3-keto reductase: fenhexamid; III-F.III Nucleic acid synthesis inhibitors III-F.III1phenylamides or acyl amino acid fungicides: benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, metalaxyl-M (mefenoxam), ofurace, and oxadixyl; III-F.III2 others: hymexazole, octhilinone, oxolinic acid, bupirimate, 5-fluorocytosine, 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine, and 5-fluoro-2-(4-fluorophenyl-methoxy)pyrimidin-4-amine; III-F.IV Inhibitors of cell division and cytoskeleton III-F.IV1 tubulin inhibitors from the class of benzimidazoles, and thiophanates: benomyl, carbendazim, fuberidazole, thiabendazole, and thiophanatemethyl; triazolopyrimidines: 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine; and III-F.IV2 other cell division inhibitors: diethofencarb, ethaboxam, pencycuron, fluopicolide, zoxamide, metrafenone, pyriofenone; III-F.V Inhibitors of amino acid and protein synthesis: III-F.V1 methionine synthesis inhibitors from the class of anilino-pyrimidines: cyprodinil, mepanipyrim, and pyrimethanil; and III-F.V2 protein synthesis inhibitors: blasticidin-S, kasugamycin, kasugamycin hydrochloride-hydrate, mildiomycin, streptomycin, oxytetracyclin, polyoxine, and validamycin A; III-F.VI Signal transduction inhibitors: III-F.VI1 MAP/histidine kinase inhibitors: fluoroimid, iprodione, procymidone, vinclozolin, fenpiclonil, and fludioxonil; and III-F.VI2 G protein inhibitors: quinoxyfen; III-F.VII Lipid and membrane synthesis inhibitors: III-F.VII1 Phospholipid biosynthesis inhibitors: edifenphos, iprobenfos, pyrazophos, isoprothiolane; III-F.VII2 lipid peroxidation: dicloran, quintozene, tecnazene, tolclofos-methyl, biphenyl, chloroneb, and etridiazole; III-F.VII3 phospholipid biosynthesis and cell wall deposition: dimethomorph, flumorph, mandipropamid, pyrimorph, benthiavalicarb, iprovalicarb, valifenalate, and N-(1-(1-(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester; III-F.VII4 compounds affecting cell membrane permeability and fatty acids: propamocarb; and III-F.VII5 fatty acid amide hydrolase inhibitors: oxathiapiprolin, 2-{3-[2-(1-{[3,5-bis(difluoromethyl-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate, 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl), and 1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate; III-F.VIII Inhibitors with Multi Site Action: III-F.VIII1 inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, and sulfur; III-F.VIII2 thio- and dithiocarbamates: ferbam, mancozeb, maneb, metam, metiram, propineb, thiram, zineb, and ziram; III-F. VIII3 organochlorine compounds from the class of phthalimides, sulfamides, and chloronitriles: anilazine, chlorothalonil, captafol, captan, folpet, dichlofluanid, dichlorophen, hexachlorobenzene, pentachlorphenole and its salts, phthalide, tolylfluanid, and N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide; and III-F.VIII4 guanidines and others: guanidine, dodine, dodine free base, guazatine, guazatine-acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon, and 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetraone; III-F.IX Cell wall synthesis inhibitors: III-F.IX1 inhibitors of glucan synthesis: validamycin, and polyoxin B; III-F.IX2 melanin synthesis inhibitors: pyroquilon, tricyclazole, carpropamid, dicyclomet, and fenoxanil; III-F.X Plant defence inducers III-F.X1 acibenzolar-S-methyl, probenazole, isotianil, tiadinil, prohexadione-calcium; III-F.X2 phosphonates: fosetyl, fosetyl-aluminum, phosphorous acid and its salts; potassium or sodium bicarbonate; and III-F.XI Unknown mode of action: bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate, diphenylamin, fenpyrazamine, flumetover, flusulfamide, flutianil, methasulfocarb, nitrapyrin, nitrothal-isopropyl, oxathiapiprolin, tolprocarb, oxin-copper, proquinazid, tebufloquin, tecloftalam, triazoxide, 2-butoxy-6-iodo-3-propylchromen-4-one, 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yl-oxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, N-(cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl acetamide, N′-(4-(4-chloro-3-trifluoro-methyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N′-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N′-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, N′-(5-difluoromethyl-2-methyl-4-(3-tri-methylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, methoxy-acetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester, 3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine (pyrisoxazole), N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic acid amide, 5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzoimidazole, 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide, ethyl (Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate, picarbutrazox, pentyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate, 2-[2-[(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phen-yl]propan-2-ol, 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline, 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, and 9-fluoro-2,2-dimethyl-5-(3-quinolyl)-3H-1,4-benzoxazepine; in a synergistically effective amount.

24. The method of claim 23, wherein at least one pesticidally active compound II is applied.

25. The method of claim 24, wherein the at least one active compound II is selected from II-M.4. A within the class of neonicotinoids from thiamethoxam, chlothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid or acetamiprid; II-M.2B within the class of fiproles from fipronil or ethiprole; II-M.3A within the class of pyrethroids alpha-cypermethrin and pyrethrum; II-M.5 within the class of spinosyns from spinosad or spinetoram; II-M.6 within the class of avermectins from abamectin or emamectin; II-M.10 within the mite growth inhibitors from etoxazole; II-M.13 within the uncouplers of oxidative phosphorylation from chlorfenapyr; II-M.21. A within the class of mitochondrial complex I electron transport inhibitors from pyridaben, tebufenpyrad, tolfenpyrad or flufenerim; II-M.25 within the class of mitochondrial complex II electron transport inhibitors from cyenopyrafen and cyflumetofen; II-M.22 within the voltage-dependent sodium channel blockers from indoxacarb or metaflumizone; II-M.23 within the inhibitors of the lipid synthesis from spirodiclofen, spiromesifen or spirotetramat; II-M.28 within the class of diamides from flubendiamide, chlorantraniliprole, cyantraniliprole, cyclaniliprole or tetraniliprole; II-M.UN within the compounds of unknown or uncertain mode of action from afidopyropene, afoxolaner, bifenazate, flupyradifurone, fluralaner, piperonyl butoxide, pyridalyl, pyrifluquinazon, sulfoxaflor or triflumezopyrim; II-M.BP-1 within the class of microbial pesticides from Bacillus firmus, B. thuringiensis ssp. israelensis, B. t. ssp. galleriae, B. t. ssp. kurstaki, Beauveria bassiana, Burkholderia sp. or Paenibacillus poppiliae.

26. The method of claim 23, wherein at least one active compound II is selected from the group consisting of thiamethoxam, chlothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, or acetamiprid.

27. The method of claim 23, wherein at least one active compound II is alpha-cypermethrin or pyrethrum.

28. The method of claim 23, wherein at least one active compound II is fipronil or ethiprole.

29. The method of claim 23, wherein at least one active compound II is spinosad.

30. The method of claim 23, wherein at least one active compound II is abamectin.

31. The method of claim 23, wherein at least one active compound II is selected from flupyradifurone or sulfoxaflor.

32. The method of claim 23, wherein at least one active compound II is a microbial pesticide.

33. The method of claim 25, wherein the fungicidally active compound III is pyraclostrobin.

34. The method of claim 25, wherein the fungicidally active compound III is fluxapyroxad.

35. The method of claim 23, comprising the at least one compound I and the at least one active compound II and/or III in a weight ratio of from 500:1 to 1:100.

36. The method of claim 23, wherein the pests are Acrosternum spp., Euschistus spp., Nezara spp and/or Piezodrus spp.

37. The method of claim 23 for controlling Pentatomidae in soybean plants and/or maize.

38. A pesticidal mixture comprising as active compounds 1) at least one compound (I), which is a component of the ginkgo tree selected from the group consisting of bilobalide, ginkgolide A, ginkgolide B, ginkgolide C, ginkgolide J and ginkgolide M, and 2) at least one pesticidally active compound (II) selected from groups M and L consisting of II-M.1 Acetylcholine esterase inhibitors: II-M.1A carbamates: aldicarb, alanycarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb and triazamate; and II-M.2. GABA-gated chloride channel antagonists: II-M.2A cyclodiene organochlorine compounds: endosulfan or chlordane; and II-M.2B fiproles: ethiprole, fipronil, flufiprole, pyrafluprole and pyriprole; II-M.3 Sodium channel modulators: II-M.3A sodium channel modulators: DDT, and methoxychlor; II-M.4 Nicotinic acetylcholine receptor agonists: II-M.4A neonicotinoids: acetamiprid, clothianidin, cycloxaprid, dinotefuran, imidacloprid, nitenpyram, thiacloprid, and thiamethoxam; II-M.4A.2 (2E-)-1-[(6-Chloropyridin-3-yl)methyl]-N′-nitro-2-pentylidenehydrazinecarboximidamide; II-M4.A.3 1-[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro-5-propoxy-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine; and II-M.4B nicotine; II-M.5 Nicotinic acetylcholine receptor allosteric activators from the class of spinosyns: spinosad, and spinetoram; II-M.6 Chloride channel activators from the class of avermectins and milbemycins: abamectin, emamectin benzoate, ivermectin, lepimectin, and milbemectin; II-M.7 Juvenile hormone mimics: II-M.7A juvenile hormone analogues: hydroprene, kinoprene, and methoprene; and II-M.7B fenoxycarb, and pyriproxyfen; II-M.8 miscellaneous non-specific inhibitors: II-M.8A alkyl halides: methyl bromide, and other alkyl halides; and II-M.8B chloropicrin, sulfuryl fluoride, borax, and tartar emetic; II-M.9 Selective homopteran feeding blockers: pymetrozine, and flonicamid; II-M.10 Mite growth inhibitors: clofentezine, hexythiazox, diflovidazin, and etoxazole; II-M.11 Microbial disruptors of insect midgut membranes: bacillus thuringiensis, bacillus sphaericus, and the insecticdal proteins they produce: bacillus thuringiensis subsp. israelensis, bacillus sphaericus, bacillus thuringiensis subsp. aizawai and bacillus thuringiensis subsp. tenebrionis, or the Bt crop proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb and Cry34/35Ab1; II-M.12 Inhibitors of mitochondrial ATP synthase: II-M.12A diafenthiuron, and organotin miticides: azocyclotin, cyhexatin, and fenbutatin oxide; and II-M.12B propargite, and tetradifon; II-M.13 Uncouplers of oxidative phosphorylation via disruption of the proton gradient: chlorfenapyr, DNOC, and sulfluramid; II-M.14 Nicotinic acetylcholine receptor channel blockers: bensultap, cartap hydrochloride, thiocyclam, and thiosultap sodium; II-M.15 Inhibitors of the chitin biosynthesis type 0: bistrifluron, chlorfluazuron, diflubenzuron, flueycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, and triflumuron; II-M.16 Inhibitors of the chitin biosynthesis type 1: buprofezin; II-M.17 Moulting disruptors: cyromazine; II-M.18 Ecdyson receptor agonists: methoxyfenozide, tebufenozide, halofenozide, fufenozide or chromafenozide; II-M.19 Octopamin receptor agonists: amitraz; II-M.20 Mitochondrial complex III electron transport inhibitors: hydramethylnon, acequinocyl, and fluacrypyrim; II-M.21 Mitochondrial complex I electron transport inhibitors: II-M.21A METI acaricides and insecticides: fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, and tolfenpyrad; and II-M.21B rotenone; II-M.22 Voltage-dependent sodium channel blockers: II-M.22A indoxacarb; II-M.22B metaflumizone; II-M.22B.1 2-[2-(4-Cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]-hydrazinecarboxamide; and II-M.22B.2 N-(3-Chloro-2-methylphenyl)-2-[(4-chlorophenyl)[4-[methyl(methylsulfonyl)amino]phenyl]methylene]-hydrazinecarboxamide; II-M.23 Inhibitors of the of acetyl CoA carboxylase of the class of tetronic and tetramic acid derivatives: spirodiclofen, spiromesifen, and spirotetramat; II-M.24 Mitochondrial complex IV electron transport inhibitors: II-M.24A phosphorous compounds: aluminium phosphide, calcium phosphide, phosphine, and zinc phosphide; and II-M.24B cyanide; II-M.25 Mitochondrial complex II electron transport inhibitors from the class of beta-ketonitrile derivatives: cyenopyrafen, and cyflumetofen; II-M.28 Ryanodine receptor-modulators from the class of diamides: flubendiamide, chlorantraniliprole (Rynaxypyr®), cyantraniliprole (Cyazypyr®), tetraniliprole; and the phthalamide compounds II-M.28.1 (R)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid; II-M.28.2 (S)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid; II-M.28.3 3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chlorpyridin-2-yl)-1H-pyrazole-5-carboxamide (proposed ISO name: cyclaniliprole); II-M.28.4 methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylate; II-M.28.5a N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; IIM.28.5b N-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; II-M.28.5c N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; II-M.28.5d N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; II-M.28.5h N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; II-M.28.5i N-[2-(5-Amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide; II-M.28.5j 3-Chloro-1-(3-chloro-2-pyridinyl)-N-[2,4-dichloro-6-[[(1-cyano-1-methylethyl)amino]carbonyl]phenyl]-1H-pyrazole-5-carboxamide; II-M.28.5k 3-Bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-1-(3,5-dichloro-2-pyridyl)-1H-pyrazole-5-carboxamide; II-M.28.5l N-[4-Chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide; and II-M.28.6: cyhalodiamide; II-M.29. insecticidal active compounds of unknown or uncertain mode of action: afidopyropen, afoxolaner, azadirachtin, amidoflumet, benzoximate, bifenazate, broflanilide, bromopropylate, chinomethionat, cryolite, dicloromezotiaz, dicofol, flufenerim, flometoquin, fluensulfone, fluhexafon, fluopyram, flupyradifurone, fluralaner, metoxadiazone, piperonyl butoxide, pyflubumide, pyridalyl, pyrifluquinazon, sulfoxaflor, tioxazafen, and triflumezopyrim; II-M.29.3: 11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one; II-M.29.4: 3-(4′-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one; II-M.29.5: 1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine, and actives on basis of bacillus firmus (Votivo, I-1582); and II-M.29.6a (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; II-M.29.6b (E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; II-M.29.6c (E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridylidene]acetamide; II-M.29.6d (E/Z)-N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; II-M.29.6e (E/Z)-N-[1-[1-(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; II-M.29.6f (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide; II-M.29.6g (E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide; II-M.29.6h (E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; II-M.29.6i (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoro-propanamide.); II-M.29.6j N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-thioacetamide; and II-M.29.6k N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-N′-isopropyl-acetamidine; II-M.29.8: fluazaindolizine; II-M.29.9.a 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide; and II-M.29.9.b fluxametamide; II-M.29.10 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1H-pyrazole; II-M.29.11.b 3-(benzoylmethylamino)-N-[2-bromo-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]-6-(trifluoromethyl)phenyl]-2-fluoro-benzamide; II-M.29.11.c 3-(benzoylmethylamino)-2-fluoro-N-[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]-benzamide; II-M.29.11. d N-[3-[[[2-iodo-4-[1, 2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; II-M.29.11.e N-[3-[[[2-bromo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]-2-fluorophenyl]-4-fluoro-N-methyl-benzamide; II-M.29.11.f 4-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; II-M.29.11.g 3-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; II-M.29.11.h 2-chloro-N-[3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-3-pyridinecarboxamide; II-M.29.11.i 4-cyano-N-[2-cyano-5-[[2,6-dibromo-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; II-M.29.11.j 4-cyano-3-[(4-cyano-2-methyl-benzoyl)amino]-N-[2,6-dichloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]-2-fluoro-benzamide; II-M.29.11.k N-[5-[[2-chloro-6-cyano-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]-phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; II-M.29.11.l N-[5-[[2-bromo-6-chloro-4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]-phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; II-M.29.11.m N-[5-[[2-bromo-6-chloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; II-M.29.11.n 4-cyano-N-[2-cyano-5-[[2,6-dichloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; II-M.29.11.o 4-cyano-N-[2-cyano-5-[[2,6-dichloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; II-M.29.11.p N-[5-[[2-bromo-6-chloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]-carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; II-M.29.12.a 2-(1,3-Dioxan-2-yl)-6-[2-(3-pyridinyl)-5-thiazolyl]-pyridine; II-M.29.12.b 2-[6-[2-(5-Fluoro-3-pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine; II-M.29.12.c 2-[6-[2-(3-Pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine; II-M.29.12.d N-Methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide; II-M.29.12.e N-Methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide; II-M.29.12.f N-Ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide; II-M.29.12.g N-Methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide; II-M.29.12.h N,2-Dimethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide; II-M.29.12.i N-Ethyl-2-methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide; II-M.29.12.j N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-2-methyl-3-methylthio-propanamide; II-M.29.12.k N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N,2-dimethyl-3-methylthio-propanamide; II-M.29.12.l N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-methyl-3-methylthio-propanamide; II-M.29.12.m N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-3-methylthio-propanamide; or the compounds II-M.29.14a 1-[(6-Chloro-3-pyridinyl)methyl]-1,2,3,5,6,7-hexahydro-5-methoxy-7-methyl-8-nitro-imidazo[1,2-a]pyridine; II-M.29.14b 1-[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridin-5-ol; II-M.29.16a 1-isopropyl-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; or II-M.29.16b 1-(1,2-dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.16c N,5-dimethyl-N-pyridazin-4-yl-1-(2,2,2-trifluoro-1-methyl-ethyl)pyrazole-4-carboxamide; II-M.29.16d 1-[1-(1-cyanocyclopropyl)ethyl]-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.16e N-ethyl-1-(2-fluoro-1-methyl-propyl)-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.16f 1-(1,2-dimethylpropyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.16g 1-[1-(1-cyanocyclopropyl)ethyl]-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.16h N-methyl-1-(2-fluoro-1-methyl-propyl]-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.16i 1-(4,4-difluorocyclohexyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; and II-M.29.16j 1-(4,4-difluorocyclohexyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; II-M.29.17a N-(1-methylethyl)-2-(3-pyridinyl)-2H-indazole-4-carboxamide; II-M.29.17b N-cyclopropyl-2-(3-pyridinyl)-2H-indazole-4-carboxamide; II-M.29.17c N-cyclohexyl-2-(3-pyridinyl)-2H-indazole-4-carboxamide; II-M.29.17d 2-(3-pyridinyl)-N-(2,2,2-trifluoroethyl)-2H-indazole-4-carboxamide; II-M.29.17e 2-(3-pyridinyl)-N-[(tetrahydro-2-furanyl)methyl]-2H-indazole-5-carboxamide; II-M.29.17f methyl 2-[[2-(3-pyridinyl)-2H-indazol-5-yl]carbonyl]hydrazinecarboxylate; II-M.29.17g N-[(2,2-difluorocyclopropyl)methyl]-2-(3-pyridinyl)-2H-indazole-5-carboxamide; II-M.29.17h N-(2,2-difluoropropyl)-2-(3-pyridinyl)-2H-indazole-5-carboxamide; II-M.29.17i 2-(3-pyridinyl)-N-(2-pyrimidinylmethyl)-2H-indazole-5-carboxamide; and II-M.29.17j N-[(5-methyl-2-pyrazinyl)methyl]-2-(3-pyridinyl)-2H-indazole-5-carboxamide; II-M.29.18a N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropylsulfanyl)-propanamide; II-M.29.18b N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropylsulfinyl)-propanamide; II-M.29.18c N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)-methylsulfanyl]-N-ethyl-propanamide; and II-M.29.18d N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)-methylsulfinyl]-N-ethyl-propanamide; II-M.29.19 sarolaner; II-M.29.20 lotilaner; II-L Biopesticides: II-L.1 Microbial pesticides with fungicidal, bactericidal, viricidal and/or plant defense activator activity: Ampelomyces quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus altitudinis, B. amyloliquefaciens, B. megaterium, B. mojavensis, B. mycoides, B. simplex, B. solisalsi, B. subtilis, B. subtilis var. amyloliquefaciens, Candida oleophila, C. saitoana, Clavibacter michiganensis (bacteriophages), Coniothyrium minitans, Cryphonectria parasitica, Cryptococcus albidus, Dilophosphora alopecuri, Fusarium oxysporum, Clonostachys rosea f. catenulate (also named Gliocladium catenulatum), Gliocladium roseum, Lysobacter antibioticus, L. enzymogenes, Metschnikowia fructicola, Microdochium dimerum, Microsphaeropsis ochracea, Muscodor albus, Paenibacillus polymyxa, Pantoea vagans, Penicillium bilaiae, Phlebiopsis gigantea, Pseudomonas sp., Pseudomonas chloraphis, Pseudozyma flocculosa, Pichia anomala, Pythium oligandrum, Sphaerodes mycoparasitica, Streptomyces griseoviridis, S. lydicus, S. violaceusniger, Talaromyces flavus, T. asperellum, T. atroviride, T. fertile, T. gamsii, T. harmatum, T. harzianum, T. polysporum, T. stromaticum, T. virens, T. viride, Typhula phacorrhiza, Ulocladium oudemansii, Verticillium dahlia, and zucchini yellow mosaic virus (avirulent strain); II-L.2Biochemical pesticides with fungicidal, bactericidal, viricidal and/or plant defense activator activity: harpin protein, and Reynoutria sachalinensis extract; II-L.3Microbial pesticides with insecticidal, acaricidal, molluscidal and/or nematicidal activity: Agrobacterium radiobacter, Bacillus cereus, B. firmus, B. thuringiensis, B. thuringiensis ssp. aizawai, B. t. ssp. israelensis, B. t. ssp. galleriae, B. t. ssp. tenebrionis, Beauveria bassiana, B. brongniartii, Burkholderia spp., Chromobacterium subtsugae, Cydia pomonella granulovirus (CpGV), Cryptophlebia leucotreta granulovirus (CrleGV), Flavobacterium spp., Helicoverpa armigera nucleopolyhedrovirus (HearNPV), Helicoverpa zea nucleopolyhedrovirus (HzNPV), Helicoverpa zea single capsid nucleopolyhedrovirus (HzSNPV), Heterorhabditis bacteriophora, Isaria fumosorosea, Lecanicillium longisporum, L. muscarium, Metarhizium anisopliae, Metarhizium anisopliae var. anisopliae, M. anisopliae var. acridum, Nomuraea rileyi, Paecilomyces fumosoroseus, P. lilacinus, Paenibacillus popilliae, Pasteuria spp., P. nishizawae, P. penetrans, P. ramosa, P. thornea, P. usgae, Pseudomonas fluorescens, Spodoptera littoralis nucleopolyhedrovirus (SpliNPV), Steinernema carpocapsae, S. feltiae, S. kraussei, Streptomyces galbus, and S. microflavus; II-L.4Biochemical pesticides with insecticidal, acaricidal, molluscidal, pheromone and/or nematicidal activity: L-carvone, citral, (E,Z)-7,9-dodecadien-1-yl acetate, ethyl formate, (E,Z)-2,4-ethyl decadienoate (pear ester), (Z,Z,E)-7,11,13-hexadecatrienal, heptyl butyrate, isopropyl myristate, lavanulyl senecioate, cis-jasmone, 2-methyl 1-butanol, methyl eugenol, methyl jasmonate, (E,Z)-2,13-octadecadien-1-ol, (E,Z)-2,13-octadecadien-1-ol acetate, (E,Z)-3,13-octadecadien-1-ol, R-1-octen-3-ol, pentatermanone, (E,Z,Z)-3,8,11-tetradecatrienyl acetate, (Z,E)-9,12-tetradecadien-1-yl acetate, Z-7-tetradecen-2-one, Z-9-tetradecen-1-yl acetate, Z-11-tetradecenal, Z-11-tetradecen-1-ol, extract of Chenopodium ambrosiodes, Neem oil, and Quillay extract; II-L.5Microbial pesticides with plant stress reducing, plant growth regulator, plant growth promoting and/or yield enhancing activity: A. lipoferum, A. irakense, A. halopraeferens, B. elkanii, B. liaoningense, B. lupini, Delftia acidovorans, Glomus intraradices, Mesorhizobium spp., Rhizobium leguminosarum bv. phaseoli, R. l. bv. trifolii, R l. bv. viciae, R. tropici, and Sinorhizobium meliloti; and/or at least one fungicidally active compound III selected from III-F.I Respiration inhibitors III-F.I1 Inhibitors of complex III at Q.sub.o site: azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fenaminstrobin, fenoxy-strobin/flufenoxystrobin, fluoxastrobin, kresoxim-methyl, mandestrobin, meto-minostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, trifloxystrobin, 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylidene-aminooxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide, pyribencarb, triclopyricarb/chlorodincarb, famoxadone, and fenamidone, methyl-N-[2-[(1,4-dimethyl-5-phenyl-pyrazol-3-yl)oxylmethyl]phenyl]-N-methoxy-carbamate, 1-[3-chloro-2-[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one, 1-[3-bromo-2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxy-methyl]phenyl]-4-methyl-tetrazol-5-one, 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one, 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one, 1-[2-[[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one, 1-[2-[[4-(4-chlorophenyl)thiazol-2-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one, 1-[3-chloro-2-[[4-(p-tolyl)thiazol-2-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one, 1-[3-cyclopropyl-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one, 1-[3-(difluoromethoxy)-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one, 1-methyl-4-[3-methyl-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]tetrazol-5-one, 1-methyl-4-[3-methyl-2-[[1-[3-(trifluoromethyl)phenyl]-ethylideneamino]oxy-methyl]phenyl]tetrazol-5-one, (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, (Z,2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, and (Z,2E)-5-[1-(4-chloro-2-fluoro-phenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide; III-F.I2 inhibitors of complex III at Q.sub.i site: cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8-benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1, 5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1,3-benzodioxol-5-ylmethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate; (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl 2-methylpropanoate, and (3S,6S,7R,8R)-8-benzyl-3-[3-[(isobutyryloxy)methoxy]-4-methoxypicolinamido]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl isobutyrate; III-F.I3 inhibitors of complex II: benodanil, benzovindiflupyr, bixafen, boscalid, carboxin, fenfuram, fluopyram, flutolanil, fluxapyroxad, furametpyr, isofetamid, isopyrazam, mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane, tecloftalam, thifluzamide, N-(4′-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)-pyrazole-4-carboxamide, 1,3,5-trimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide, N-(7-fluoro-1,1,3-trimethyl-indan-4-yl)-1,3-dimethyl-pyrazole-4-carboxamide, and N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide; III-F.I4 other respiration inhibitors: diflumetorim, (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl}-amine; nitrophenyl derivates: binapacryl, dinobuton, dinocap, fluazinam, ferimzone; organometal compounds: fentin-acetate, fentin chloride, and fentin hydroxide; ametoctradin; and silthiofam; III-F.II Sterol biosynthesis inhibitors: III-F.II1 C14 demethylase inhibitors: triazoles: azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, oxpoconazole, paclobutrazole, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, 1-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-5-thio-cyanato-1H-[1,2,4]triazolo, 2-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol, 1-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-cyclopropyl-2-(1,2,4-triazol-1-yl)ethanol, 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol, 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1-(1, 2,4-triazol-1-yl)butan-2-ol, 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)-phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol, 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol, 2-[4-(4-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)pent-3-yn-2-ol; imidazoles: imazalil, pefurazoate, prochloraz, triflumizol; pyrimidines, pyridines and piperazines: fenarimol, nuarimol, pyrifenox, triforine, and [3-(4-chloro-2-fluoro-phenyl)-5-(2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol; III-F.II2 Delta14-reductase inhibitors: aldimorph, dodemorph, dodemorph-acetate, fenpropimorph, tridemorph, fenpropidin, piperalin, and spiroxamine; III-F.II3 Inhibitors of 3-keto reductase: fenhexamid; III-F.III Nucleic acid synthesis inhibitors III-F.III1phenylamides or acyl amino acid fungicides: benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, metalaxyl-M (mefenoxam), ofurace, and oxadixyl; III-F.III2 others: hymexazole, octhilinone, oxolinic acid, bupirimate, 5-fluorocytosine, 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine, and 5-fluoro-2-(4-fluorophenyl-methoxy)pyrimidin-4-amine; III-F.IV Inhibitors of cell division and cytoskeleton III-F.IV1 tubulin inhibitors from the class of benzimidazoles, and thiophanates: benomyl, carbendazim, fuberidazole, thiabendazole, and thiophanatemethyl; triazolopyrimidines: 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine; and F.IV2 other cell division inhibitors: diethofencarb, ethaboxam, pencycuron, fluopicolide, zoxamide, metrafenone, pyriofenone; III-F.V Inhibitors of amino acid and protein synthesis: III-F.V1 methionine synthesis inhibitors from the class of anilino-pyrimidines: cyprodinil, mepanipyrim, and pyrimethanil; and III-F.V2 protein synthesis inhibitors: blasticidin-S, kasugamycin, kasugamycin hydrochloride-hydrate, mildiomycin, streptomycin, oxytetracyclin, polyoxine, and validamycin A; III-F.VI Signal transduction inhibitors: F.VII MAP/histidine kinase inhibitors: fluoroimid, iprodione, procymidone, vinclozolin, fenpiclonil, and fludioxonil; and III-F.VI2 G protein inhibitors: quinoxyfen; III-F.VII Lipid and membrane synthesis inhibitors: F.VII1Phospholipid biosynthesis inhibitors: edifenphos, iprobenfos, pyrazophos, isoprothiolane; F.VII2 lipid peroxidation: dicloran, quintozene, tecnazene, tolclofos-methyl, biphenyl, chloroneb, and etridiazole; F.VII3 phospholipid biosynthesis and cell wall deposition: dimethomorph, flumorph, mandipropamid, pyrimorph, benthiavalicarb, iprovalicarb, valifenalate, and N-(1-(1-(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester; III-F.VII4 compounds affecting cell membrane permeability and fatty acids: propamocarb; and III-F.VII5 fatty acid amide hydrolase inhibitors: oxathiapiprolin, 2-{3-[2-(1-{[3,5-bis(difluoromethyl-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate, 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl), and 1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate; III-F.VIII Inhibitors with Multi Site Action: III-F.VIII1 inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, and sulfur; III-F.VIII2 thio- and dithiocarbamates: ferbam, mancozeb, maneb, metam, metiram, propineb, thiram, zineb, and ziram; III-F. VIII3 organochlorine compounds from the class of phthalimides, sulfamides, and chloronitriles: anilazine, chlorothalonil, captafol, captan, folpet, dichlofluanid, dichlorophen, hexachlorobenzene, pentachlorphenole and its salts, phthalide, tolylfluanid, and N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide; and III-F.VIII4 guanidines and others: guanidine, dodine, dodine free base, guazatine, guazatine-acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon, and 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetraone; III-F.IX Cell wall synthesis inhibitors: III-F.IX1 inhibitors of glucan synthesis: validamycin, and polyoxin B; III-F.IX2 melanin synthesis inhibitors: pyroquilon, tricyclazole, carpropamid, dicyclomet, and fenoxanil; III-F.X Plant defence inducers III-F.X1 acibenzolar-S-methyl, probenazole, isotianil, tiadinil, prohexadione-calcium; III-F.X2 phosphonates: fosetyl, fosetyl-aluminum, phosphorous acid and its salts; potassium or sodium bicarbonate; and III-F.XI Unknown mode of action: bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate, diphenylamin, fenpyrazamine, flumetover, flusulfamide, flutianil, methasulfocarb, nitrapyrin, nitrothal-isopropyl, oxathiapiprolin, tolprocarb, oxin-copper, proquinazid, tebufloquin, tecloftalam, triazoxide, 2-butoxy-6-iodo-3-propylchromen-4-one, 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, N-(cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-di-fluoro-phenyl)-methyl)-2-phenyl acetamide, N′-(4-(4-chloro-3-trifluoro-methyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N′-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N′-(2-methyl-5-trifluoromethyl-4-(3-trimethyl-silanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, N′-(5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, methoxy-acetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester, 3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine (pyrisoxazole), N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic acid amide, 5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzoimidazole, 2-(4-chloro-phenyl)-N-[4-(3,4-dimeth-oxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide, ethyl (Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate, picarbutrazox, pentyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate, 2-[2-[(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]-phen-yl]propan-2-ol, 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline, 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, and 9-fluoro-2,2-dimethyl-5-(3-quinolyl)-3H-1,4-benzoxazepine; in a synergistically effective amount.

39. The pesticidal mixture of claim 38, wherein at least one active compound (II) is selected from the group consisting of thiamethoxam, acetamiprid, chlothianidin, dinotefuran, imidacloprid, nitenpyram and thiacloprid and/or wherein at least one active compound II is spinosad, and/or wherein at least one active compound II is abamectin, at least one active compound II is a microbial pesticide, preferably Beauveria bassiana.

40. The pesticidal mixture of claim 38, comprising a fungicidally active compound III which is pyraclostrobin, and/or fluxapyroxad, and/or mancozeb and/or amectotradin, and/or carbendazim, and/or iprodione and/or prochloraz, and/or chlorothalonil, and/or azoxystrobin, trifloxystrobin or picoxystrobin, and/or fenhexamid, and/or pyrimethanil, and/or epoxiconazol or difenoconazol.

41. The pesticidal mixture of claim 38, comprising at least one compound I, and at least one active compound II and/or III in a weight ratio of from 10000:1 to 1:10.

42. A seed treated with the mixture of claim 38 in an amount of from 0.1 g to 100 kg per 100 kg of seeds.

43. A pesticidal composition comprising a liquid or solid carrier and the mixture of claim 38.

Description

EXAMPLES

A. Compounds

[0940] Bilobalide, ginkgolide A, ginkgolide B, ginkgolide C and ginkgolide J are commercially available (e.g. from Interchim).

B. Biology

[0941] Synergism can be described as an interaction where the combined effect of two or more compounds is greater than the sum of the individual effects of each of the compounds. The pres-ence of a synergistic effect in terms of percent control, between two mixing partners (X and Y) can be calculated using the Colby equation (Colby, S. R., 1967, Calculating Synergistic and Antagonistic Responses in Herbicide Combinations, Weeds, 15, 20-22):

[00001]$E=X+Y-\frac{\mathrm{XY}}{100}$

[0942] When the observed combined control effect is greater than the expected combined control effect (E), then the combined effect is synergistic.

[0943] The following tests demonstrate the control efficacy of compounds, mixtures or compositions of this invention on specific pests. However, the pest control protection afforded by the compounds, mixtures or compositions is not limited to these species. In certain instances, combinations of a compound of this invention with other invertebrate pest control compounds or agents are found to exhibit synergistic effects against certain important invertebrate pests. The analysis of synergism or antagonism between the mixtures or compositions was determined using Colby's equation.

[0944] The following abbreviations were used:

MTP: microtiter plate

Test 1

[0945] For evaluating control of boll weevil (Anthonomus grandis) the test unit consisted of microtiter plates (MTPs) containing an insect diet and 20-30 A. grandis eggs.

[0946] The compounds or mixtures were formulated using a solution containing 75% water and 25% DMSO. Different concentrations of formulated compounds or mixtures were sprayed onto the insect diet at 20 μl, using a custom built micro atomizer, at two replications.

[0947] For experimental mixtures in these tests identical volumes of both mixing partners at the desired concentrations respectively, were mixed together.

[0948] After application, MTPs were incubated at 23±1° C., 50±5% room humidity for 5 days. Egg and larval mortality was then visually assessed. For the mixture tested the results are listed in Table 1.

TABLE-US-00003 TABLE 1 Calculated Active efficacy compound/ Concentration Observed according active mixture (ppm) Ratio efficacy (%) to Colby (%) Dinotefuran 0.08 — 0 — Bilobalide 160 — 0 — Dinotofuran + 0.08 1:2000 100  0 Bilobalide 160 Imidacloprid + 0.8 — 25 — Bilobalide 160 — 0 — Imidacloprid + 0.8 1:2000 100 25 Bilobalide 160 Abamectin 0.003 — 0 — Bilobalide 64 — 25 — Abamectin + 0.003 1:21333 75 25 Bilobalide 64 Imicacloprid 0.8 — 0 — Ginkgolide A 20 — 0 — Imidacloprid + 0.8 1:25 50  0 Ginkgloide A 20

Test 2

[0949] For evaluating control of Mediterranean fruitfly (Ceratitis capitata) the test unit consisted MTPs containing an insect diet and 50-80 C. capitata eggs. The compounds or mixtures were formulated using a solution containing 75% water and 25% DMSO. Different concentrations of formulated compounds or mixtures were sprayed onto the insect diet at 5 μl, using a custom built micro atomizer, at two replications. For experimental mixtures in these tests identical volumes of both mixing partners at the desired concentrations respectively, were mixed together. After application, MTPs were incubated at 28±1° C., 80±5% room humidity for 5 days. Egg and larval mortality was then visually assessed. For the mixture tested the results are listed in Table 2.

TABLE-US-00004 TABLE 2 Calculated efficacy Active Observed according compound/ Concentration efficacy to active mixture (ppm) Ratio (%) Colby (%) Thiamethoxam 0.08 — 0 — Bilobalide 160 — 0 — Thiamethoxam + 0.08 1:2000 75 0 Bilobalide 160 Alphacypermethrin 0.4 — 0 — Bilobalide 160 — 0 — Alphacypermethrin + 0.4 1:4000 50 0 Bilobalide 160

Test 3

[0950] For evaluating control of tobacco budworm (Heliothis virescens) the test unit consisted of MTPs containing an insect diet and 15-25 H. virescens eggs. The compounds or mixtures were formulated using a solution containing 75% water and 25% DMSO. Different concentrations of formulated compounds or mixtures were sprayed onto the insect diet at 10 μl, using a custom built micro atomizer, at two replications. For experimental mixtures in these tests identical volumes of both mixing partners at the desired concentrations respectively, were mixed together. After application, MTPs were incubated at 28±1° C., 80±5% room humidity for 5 days. Egg and larval mortality was then visually assessed. The results were listed in Table 3.

TABLE-US-00005 TABLE 3 Calculated efficacy Active Observed according compound/ Concentration efficacy to active mixture (ppm) Ratio (%) Colby (%) Dinotefuran 0.08 — 0 — Bilobalide 400 — 0 — Dinotefuran + 0.08 1:5000 50 0 Bilobalide 400 Alphacypermethrin 0.08 — 0 — Bilobalide 400 — 0 — Alphacypermethrin + 0.08 1:5000 50 0 Bilobalide 400

Test 4

[0951] For evaluating control of yellow fever mosquito (Aedes aegypti) the test unit consisted of MTPs containing 200 μl water per well and 5-15 freshly hatched A. aegypti larvae. The compounds or mixtures were formulated using a solution containing 75% water and 25% DMSO. Different concentrations of formulated compounds or mixtures were sprayed onto the insect diet at 2.5 μl, using a custom built micro atomizer, at two replications. For experimental mixtures in these tests identical volumes of both mixing partners at the desired concentrations respectively, were mixed together. After application, MTPs were incubated at 28±1° C., 80±5% room humidity for 2 days. Larval mortality was then visually assessed. The results were listed in Table 4.

TABLE-US-00006 TABLE 4 Calculated Active efficacy compound/ Concentration Observed according to active mixture (ppm) Ratio efficacy (%) Colby (%) Thiamethoxam 0.8 — 50 — Bilobalide 160 — 0 — Thiamethoxam + 0.08 1:200 100 50 Bilobalide 400

Test 5

[0952] For evaluating control of southern green stink bug (Nezara viridula) the compounds or mixtures were formulated using a solution containing acetone and water (50:50) and 0.01% kinetic. Whole Green Beans are rinsed in a 1% bleach solution, triple rinsed with deionised water, and allowed to air dry at least 30 minutes in the fume hood. Beans were dipped in treatment solutions for 5 seconds and allowed to air dry for 30 minutes in the fume hood. For maximum expo-sure, southern green stink bug (4.sup.th instar) were dipped in treatment solution for 3 seconds and allowed to air dry in a cup lined with filter paper and closed with a vented lid for 10 minutes in the fume hood. Three beans were placed in 500 ml deli cups with a 70 mm dry filter paper in the bottom and a 29.5 ml portion cup with a cotton wick for water, and infested with 4 southern green stink bug per cup. Each treatment was replicated 3-fold. Assay arenas were held at 27° C. and 45% room humidity. Data were recorded after 5 days as number of insects alive, with dead recorded as such and all others recorded as alive. The results were listed in Table 5.

TABLE-US-00007 TABLE 5 Calculated Active efficacy compound/ Concentration Observed according active mixture (ppm) Ratio efficacy (%) to Colby (%) Spinosad 10 — 17 — Ginkgolide A 5 — 58 — Spinosad + 10 2:1 92 65 Ginkgolide A 5 Pyrethrum 10 — 25 — Ginkgolide A 5 — 58 — Pyrethrum + 10 2:! 92   68.5 Ginkgolide A 5 Pyraclostrobin 10 — 0 — Ginkgolide A 5 — 58 — Pyraclostrobin + 10 2:1 67 58 Bilobalide 5 Fluxapyroxad 10 — 0 — Ginkgolide A 5 — 58 — Fluxapyroxad + 10 2:1 67 58 Ginkgloide A 5

Test 6

[0953] For evaluating control of different pathogens in a microtest the active compounds were formulated separately as a stock solution having a concentration of 10000 ppm in dimethyl sulfoxide. The percentages were converted into efficacies. An efficacy of 0 means that the growth level of the pathogens corresponds to that of the untreated control; an efficacy of 100 means that the pathogens were not growing.

[0954] The expected efficacies of active compound mixtures were determined using Colby's formula [R. S. Colby, “Calculating synergistic and antagonistic responses of herbicide combinations”, Weeds 15, 20-22 (1967)] and compared with the observed efficacies.

Test 6-1. Activity Against the Late Blight Pathogen Phytophthora infestans

[0955] The stock solutions were mixed according to the ratios in Table 6, pipetted onto a MTP and diluted with water to the concentrations in Table 6. A spore suspension of Phytophtora infestans containing a pea juice-based aqueous nutrient medium or DDC medium was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation. The results were listed in Table 6.

TABLE-US-00008 TABLE 6 Calculated Active efficacy compound/ Concentration Observed according active mixture (ppm) Ratio efficacy (%) to Colby (%) Mancozeb 0.063 — 39 — Bilobalide 1 — 24 — Mancozeb + 0.063 1:16 80 53  Bilobalide 1 Mancozeb 0.016 — 15 — Bilobalide 0.25 — 4 — Mancozeb + 0.016 1:16 54 18  Bilobalide 0.25 Mancozeb 0.004 — 0 — Bilobalide 0.063 — 0 — Mancozeb + 0.016 1:16 28 0 Bilobalide 0.25 Mancozeb 0.016 — 15 — Bilobalide 1 — 24 — Mancozeb + 0.016 1:63 62 35  Bilobalide 1 Mancozeb 0.004 — 0 — Bilobalide 0.25 — 4 — Mancozeb + 0.004 1:63 23 4 Bilobalide 0.25 Ametoctradin 0.004 — 0 — Bilobalide 0.25 — 4 — Ametoctradin + 0.004 1:63 26 4 Bilobalide 0.25 Carbendazim 0.004 — 0 — Bilobalide 0.25 — 4 — Carbendazim + 0.004 1:63 29 4 Bilobalide 0.25 Iprodion 0.004 — 0 — Bilobalide 0.25 — 4 — Iprodion + 0.004 1:63 26 4 Bilobalide 0.25 Prochloraz 0.016 — 3 — Bilobalide 0.25 — 4 Prochloraz + 0.016 1:16 26 6 Bilobalide 0.25 Mancozeb 1 — 20 — Ginkgolide A 63 — 38 Mancozeb + 1 1:63 97 51  Ginkgolide A 63
Test 6-2. Activity Against the Grey Mold Botrytis cinerea

[0956] The stock solutions were mixed according to the ratios in Table 7, pipetted onto a MTP and diluted with water to the concentrations in Table 7. A spore suspension of Botrci cinerea in an aqueous biomalt or yeast-bactopeptone-sodiumacetate solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation. The results were listed in Table 7.

TABLE-US-00009 TABLE 7 Calculated efficacy Active compound/ Observed according active mixture Concentration Ratio efficacy (%) to Colby (%) Chlorothalonil 4 — 53 — Bilobalide 63 — 1 — Chlorothalonil + 4 1:16 95 56 Bilobalide 63 Prochloraz 4 — 39 — Ginkgolide A 63 — 4 — Prochloraz + 4 1:16 80 41 Ginkgolide A 63
Test 6-3. Activity Against Rice Blast Pyricularia oryzae

[0957] The stock solutions were mixed according to the ratios in Table 8, pipetted onto a MTP and diluted with water to the concentrations in Table 8. A spore suspension of Pyricularia oryzae in an aqueous biomalt or yeast-bactopeptone-glycerine solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation. The results were listed in Table 8.

TABLE-US-00010 TABLE 8 Calculated Active efficacy compound/ Observed according active mixture Concentration Ratio efficacy (%) to Colby (%) Pyraclostrobin 0.016 — 46 — Bilobalide 16 — 1 — Pyraclostrobin + 0.016 1:1000 80 46 Bilobalide 16 Pyraclostrobin 0.016 — 46 — Bilobalide 4 — 3 — Pyraclostrobin + 0.016 1:250 73 47 Bilobalide 4 Azoxystrobin 0.25 — 45 — Bilobalide 63 — 5 — Azoxystrobin + 0.25 1:252 82 48 Bilobalide 63 Azoxystrobin 0.25 — 45 — Bilobalide 16 — 1 — Azoxystrobin + 0.25 1:64 69 45 Bilobalide 16 Chlorothalonil 0.25 — 13 — Bilobalide 16 — 1 — Chlorothalonil + 0.25 1:64 99 14 Bilobalide 16 Chlorothalonil 0.25 — 13 — Bilobalide 4 — 3 — Chlorothalonil + 0.25 1:16 52 16 Bilobalide 4 Trifloxystrobin 0.063 — 24 — Bilobalide 63 — 5 — Trifloxystrobin + 0.063 1:1000 65 28 Bilobalide 63 Mancozeb 1 — 11 — Bilobalide 63 — 5 — Mancozeb + 1 1:63 98 16 Bilobalide 63 Chlorothalonil 0.25 — 15 — Ginkgolide A 4 — 0 — Chlorothalonil + 0.25 1:16 100 15 Ginkgolide A 4 Chlorothalonil 0.25 — 15 — Ginkgolide A 16 — 0 — Chlorothalonil + 0.25 1:64 100 15 Ginkgolide A 16 Trifloxystrobin 0.063 — 24 — Ginkgolide A 16 — 0 — Chlorothalonil + 0.063 1:1000 55 26 Ginkgolide A 16 Fenhexannid 1 — 40 — Ginkgolide A 16 — 0 Fenhexamid + 1 1:16 64 40 Ginkgolide A 16 Pyrimethalin 4 — 27 — Ginkgolide A 63 — 3 — Pyrimethalin + 4 1:16 60 29 Ginkgolide A 63
Test 6-4. Activity Against Leaf Blotch on Wheat Caused by Septoria tritici

[0958] The stock solutions were mixed according to the ratios in Table 9, pipetted onto a MTP and diluted with water to the concentrations in Table 9. A spore suspension of Septoria tritici in an aqueous biomalt or yeast-bactopeptone-glycerine solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation. The results were listed in Table 9.

TABLE-US-00011 TABLE 9 Calculated efficacy Active compound/ Observed according active mixture Concentration Ratio efficacy (%) to Colby (%) Trifloxystrobin 0.016 — 67 — Bilobalide 4 — 8 — Trifloxystrobin + 0.016 1:250 99 70 Bilobalide 4 Trifloxystrobin 0.004 — 7 — Bilobalide 1 — 6 — Trifloxystrobin + 0.004 1:250 70 13 Bilobalide 1 Pyraclostrobin 0.004 — 59 — Bilobalide 1 — 6 — Pyraclostrobin + 0.004 1:250 90 61 Bilobalide 1 Epoxiconazol 0.25 — 35 — Bilobalide 16 — 9 — Epoxiconazol + 0.25 1:64 70 40 Bilobalide 16 Prochloraz 4 — 49 — Ginkgolide A 63 — 16 — Prochloraz + 4 1:16 83 57 Ginkgolide A 63
Test 6-5. Activity Against Early Blight Caused by Alternaria solani

[0959] The stock solutions were mixed according to the ratios in Table 10, pipetted onto a MTP and diluted with water to the concentrations in Table 10. A spore suspension of Alternaria solani in an aqueous biomalt or yeast-bactopeptone-glycerine solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation. The results were listed in Table 10.

TABLE-US-00012 TABLE 10 Calculated efficacy Active compound/ Observed according active mixture Concentration Ratio efficacy (%) to Colby (%) Fenhexamid 4 — 46 — Bilobalide 16 — 0 — Fenhexamide + 4 1:4 77 48 Bilobalide 16 Difenoconazol 1 — 0 — Bilobalide 63 — 0 — Difenoconazol + 1 1:63 34  0 Bilobalide 63 Fluoxastrobin 0.25 — 11 — Ginkgolide A 63 — 0 — Fluoxastrobin + 0.25 1:252 81 11 Ginkgolide A 63 Epoxiconazol 0.25 — 36 — Ginkgolide A 16 — 0 — Epoxiconazol + 0.25 1:63 66 36 Ginkgolide A 16 Picoxystrobin 0.25 — 39 — Ginkgolide A 63 — 0 — Picoxystrobin + 0.25 1:252 61 39 Ginkgolide A 63
Test 6-6. Activity Against Wheat Leaf Spots Caused by Leptosphaeria nodorum

[0960] The stock solutions were mixed according to the ratios in Table 11, pipetted onto a MTP and diluted with water to the concentrations in Table 11. A spore suspension of Leptosphaeria nodorum in an aqueous biomalt or yeast-bactopeptone-glycerine solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation. The results were listed in Table 11.

TABLE-US-00013 TABLE 11 Calculated efficacy Active compound/ Observed according active mixture Concentration Ratio efficacy (%) to Colby (%) Chlorothalonil 1 — 39 — Ginkgolide A 63 — 18 — Chlorothalonil + 1 1:63 70 50 Ginkgolide A 63 Difenoconazol 1 — 21 — Bilobalide 63 — 24 — Difenoconazol + 1 1:63 76 40 Bilobalide 63

Test 7

[0961] Compatibility of bilobalide with Beauveria bassiana strain PPRI 5339 was analyzed. Aqueous mixtures containing 100 ppm of bilobalide, and 4×10E 7 CFU/ml of Beauveria bassiana strain PPRI 5339 were filled in bottles. Bottles were shaken to ascertain complete dilution and incubated at room temperature (26° C.). The aqueous mixtures were maintained for 1 hour, or 24 hours. Ten-fold serial dilutions were made for both incubation times from 1:10E 0 to 1:10E 10. A fixed volume (100 μl) of each dilution was distributed aseptically onto petri dishes containing Dichloran-Rose-Bengal-Chlortetracycline agar for culture. Petri dishes were incubated in a dark chamber at 28° C. for five days and submitted to visual inspection. Analyzed parameters were the number of colonies, colony diameter, shape, color, and speed of growth. The results showed that Beauveria bassiana strain PPRI 5339 and Bilobalide were compatible under all tested conditions.

[0962] For evaluating control of southern green stink bug (Nezara viridula), Bilobalide, Beauveria bassiana strain PPRI 5339, or mixtures thereof were formulated using a solution containing water and acetone (98.75:1.25). Beauveria bassiana strain PPRI 5339 was at room temperature for one hour before use.

[0963] Seven days old Lima bean plants were dipped into each treatment. Once dried, plants were artificially infested with four second instar southern green stink bugs. Percentage of mortality (sick+ death insects) was evaluated at 5 days. The results were listed in Table 12.

TABLE-US-00014 TABLE 12 Calculated Active Observed efficacy compound/ efficacy according active mixture Concentration Ratio (%) to Colby (%) Beauveria 4 × 10E7 CFU/ml — 37 — bassiana strain PPRI 5339 Bilobalide 50 ppm — 33 — Beauveria 4 × 10E7 CFU/ml 2 × 10E5 100 58 bassiana 50 ppm CFU/ strain ml:1 ppm PPRI 5339 + Bilobalide